BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Davidson M, Chau I, Cunningham D, Khabra K, Iveson T, Hickish T, Seymour M, Starling N. Impact of tumour histological subtype on chemotherapy outcome in advanced oesophageal cancer. World J Gastrointest Oncol 2017; 9(8): 333-340 [PMID: 28868114 DOI: 10.4251/wjgo.v9.i8.333]
URL: https://www.wjgnet.com/1948-5204/full/v9/i8/333.htm
Number Citing Articles
1
Aneta Polewko-Klim, Sibo Zhu, Weicheng Wu, Yijing Xie, Ning Cai, Kexun Zhang, Zhen Zhu, Tao Qing, Ziyu Yuan, Kelin Xu, Tiejun Zhang, Ming Lu, Weimin Ye, Xingdong Chen, Chen Suo, Witold R. Rudnicki. Identification of Candidate Therapeutic Genes for More Precise Treatment of Esophageal Squamous Cell Carcinoma and AdenocarcinomaFrontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.844542
2
Young Sun Hwang. Ethanol Extract of Smilax glabra Induces Apoptotic Cell Death in Human YD10B Oral Squamous Cell Carcinoma CellsJournal of Dental Hygiene Science 2023; 23(3): 216 doi: 10.17135/jdhs.2023.23.3.216
3
Hanneke WM van Laarhoven. Is chemotherapy for advanced or metastatic oesophageal squamous cell carcinoma no longer needed?The Lancet Oncology 2020; 21(6): 743 doi: 10.1016/S1470-2045(20)30182-0
4
Xiaoxuan Duan, Yihuan Chen, Kai Zhang, Wei Chen, Jun Zhao, Xiaoshuo Dai, Wenbo Cao, Ziming Dong, Saijun Mo, Jing Lu. PHGDH promotes esophageal squamous cell carcinoma progression via Wnt/β-catenin pathwayCellular Signalling 2023; 109: 110736 doi: 10.1016/j.cellsig.2023.110736
5
Bulent Cetin, Chiara A Wabl, Ozge Gumusay. Advancing immunotherapy in gastroesophageal cancer through rational combinations and biomarkersImmunotherapy 2023; 15(12): 945 doi: 10.2217/imt-2022-0287
6
Michael G Penniment, Paolo B De Ieso, Jennifer A Harvey, Sonya Stephens, Heather-Jane Au, Christopher J O'Callaghan, Andrew Kneebone, Samuel Y Ngan, Iain G Ward, Rajarshi Roy, Jennifer G Smith, Tirath Nijjar, James J Biagi, Liam A Mulroy, Rebecca Wong. Palliative chemoradiotherapy versus radiotherapy alone for dysphagia in advanced oesophageal cancer: a multicentre randomised controlled trial (TROG 03.01)The Lancet Gastroenterology & Hepatology 2018; 3(2): 114 doi: 10.1016/S2468-1253(17)30363-1